3 matokeo
The present invention relates to immunostimulatory oligodeoxynucleic molecules (ODNs) and pharmaceutical compositions containing such ODNs.
Vaccines can save more lives (and resources) than any other medical intervention (Nossal, 1998). Owing to world-wide vaccination programs the incidence of many
This application is a U.S. national phase application under 35 U.S.C. .sctn.371 of PCT Application No. PCT/EP01/06433 filed Jun. 7, 2001, which claims priority to Austrian Application Nos. A 1973/2000 filed Nov. 23, 2000 and A 1000/2000 filed Jun. 8, 2000, the entire texts of which are specifically
This application is a U.S. national phase application under 35 U.S.C. .sctn.371 of International Application No. PCT/EP02/05448 filed 17 May 2002, which claims priority to Austrian Application No. A 805/2001 filed 21 May 2001.
The present invention relates to immunostimulatory oligodeoxynucleic